Microbiology Testing Market (2025-2032)
The Microbiology Testing Market is projected to reach $21.4 billion by 2032, at a CAGR of 5.9% during 2025–2032.
- Published
- Jan 2025
- Pages
- 210
- Format
- PDF + Excel
- Report ID
- MRHC - 104778
- Base year
- 2024
- 2032 · FORECAST
- $21.40B
- 2032
- $21.40B
- CAGR 2025–2032
- 5.9%
2024 baseline · 2025–2032 forecast at 5.9% CAGR · hover a bar for the value
Key highlights
In 2025, the Laboratory Instruments and Analysers Segment is Expected to Dominate the Microbiology Testing Market
In 2025, the Bacteria Segment is Expected to Dominate the Microbiology Testing Market
In 2025, the Diagnostic Testing Segment is Expected to Dominate the Microbiology Testing Market
In 2025, the Hospitals and Diagnostic Labs Segment is Expected to Dominate the Microbiology Testing Market
Report summary
| Particulars | Details |
|---|---|
| Base Year | 2024 |
| Estimated Year | 2025 |
| Forecast Period | 2025–2032 |
| Market Size (2032) | USD 21.40 billion |
| CAGR (2025–2032) | 5.9% |
| Format | PDF, Excel & Cloud Portal · 210 pages |
| Segments Covered | By Product: Laboratory Instruments and Analyzers Microbial Identification Systems, PCR Systems, Mass Spectrometers, High-performance Liquid Chromatography (HPLC) Systems, Laminar Air Flow Systems, Microbial Air Samplers, Stainer, Cell/Colony Counters, Media Preparators, Incubators, Autoclave, Microscopes, Other Laboratory Instruments and Analyzers · By Microorganism Type: Bacteria, Fungi, Other Microorganism Types · By Application: Pharmaceutical Testing, Diagnostic Testing, Food and Beverage Testing, Environmental Testing, Cosmetic Testing, Other Applications · By End User: Hospitals and Diagnostic Labs, Analytical and Quality Testing Laboratories, Academic & Research Institutes · By Microorganism: Bacteria, Fungi, Virus |
| Countries Covered | Europe (RoE), Asia-Pacific (RoAPAC) |
| Key Companies | Danaher Corporation (U.S.), Becton, Dickinson and Company (U.S.), F. Hoffmann-La Roche Ltd, Bruker Corporation (U.S.), Hologic, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Merck KGaA, Intertek Group plc (U.K.), Eurofins Scientific S.E, Agilent Technologies, Inc. (U.S.) |
Report overview
Segments covered: product, microorganism type, application, end user, microorganism. Regions: Europe, Asia-Pacific.
Microbiology tests are conducted in various industries such as pharmaceutical, diagnostic, food & beverage, cosmetic, and other industries to detect and restrict harmful microorganisms. The report covers microbiology testing products such as laboratory instruments and analyzers; kits and reagents; and other products, including petri dishes, pipettes, swabs, sterile pack bottles, and plates, to detect various microorganisms such as bacteria, fungi, viruses, and protozoa. These products are majorly used by hospitals and diagnostic labs, analytical and quality laboratories, and academic & research institutes.
The growth of this market is driven by the increasing burden of infectious diseases and outbreaks of epidemics, stringent regulations for microbial contamination in pharmaceutical and food & beverage manufacturing, technological advancements in microbiology testing, and the increasing private-public funding for research on infectious diseases.
The key players operating in the microbiology testing market experienced an initial shrinkage due to operational restrictions imposed on various industries globally. However, after the initial shrinkage, the COVID-19 pandemic positively impacted the global microbiology testing market and created growth opportunities for the key players operating in this market. With increasing health safety concerns amid the COVID-19 pandemic, microbiology testing emerged as a crucial tool to fight against the outbreak.
There is an increased demand for microbiology testing in various industries, including pharmaceutical, diagnostic, food & beverage, cosmetic, and other industries, as the COVID-19 pandemic has forced industries to adopt stringent Total Quality Assurance (TQA) policies. Many countries have loosened up the pandemic restrictions due to a low number of new COVID-19 infections and a rising number of people vaccinated against the disease. Various industries have started to work normally, which is creating demand for microbiology testing products and services.
The increasing funding for research on infectious diseases has a significant impact on the growth of the global microbiology testing market. These fundings enable the development of new and advanced microbiology testing technologies and methods, which further leads to the production of more accurate and rapid diagnostic products. For example, in June 2022, the [SK1] U.S. Centers for Disease Control and Prevention (CDC) announced a funding of USD 122.47 million to three Indian medical research institutions, namely, the Indian Council of Medical Research (ICMR), National Institute of Virology (NIV), and National Institute of Epidemiology (NIE)), to prevent avoidable epidemics and support rapid and effective epidemiology and outbreak response and for the early detection of disease threats. This kind of funding allows the development of new and improved methods for detecting infectious diseases and the introduction of advanced molecular diagnostic techniques, such as polymerase chain reaction (PCR). Thus, the increase in funding for research on infectious diseases is driving innovation and improvement in the field of microbiology testing, which is further driving the growth of this market.
Report infographic
Table of contents
12 chapters · 104 sections · 210 pages · click to expandSegmental analysis
| Segment | Largest share (2025) | Fastest growth (2025–2032) |
|---|---|---|
| By Product | Laboratory Instruments and Analysers | — |
| By Microorganism Type | Bacteria | — |
| By Application | Diagnostic Testing | — |
| By End User | Hospitals and Diagnostic Labs | — |
By Product
- The laboratory instruments and analysers segment is expected to account for the largest share of the microbiology testing market.
- The large market share of this segment is primarily attributed to rising private-public funding for research on infectious diseases and technological advancements in microbiology testing.
By Microorganism Type
- The bacteria segment is expected to account for the largest share of the microbiology testing market.
- The large market share of this segment is primarily attributed to the number of foodborne diseases caused by bacteria and stringent regulations for bacterial contamination in food & beverage manufacturing.
- Bacterial contamination is the most common type of contamination in many industries.
- Bacterial contamination is the most common type of contamination in many industries.
- For example, bacteria such as Bacillus cereus, Campylobacter, Clostridium perfringens, and E. coli are considered harmful when it comes to food safety.
- It is also the most common cause of food poisoning.
- Thus, food manufacturing companies need to strictly comply with GMP guidelines and take additional efforts to ensure that the food is processed in hygienic conditions and free from microbial contaminations.
- The large market share of this segment is primarily attributed to the large number of foodborne diseases caused by bacteria and stringent regulations for bacterial contamination in food & beverage manufacturing.
By Application
- The diagnostic testing segment is expected to account for the largest share of the microbiology testing market.
- The large market share of this segment is primarily attributed to the rising burden of infectious diseases and outbreaks of epidemics, technological advancements in microbiology testing, rising awareness about early diagnosis and food safety, the need to comply with the regulatory guidelines in respective industries, and improving healthcare expenditure.
By End User
- The hospitals and diagnostic labs segment is expected to account for the largest share of the microbiology testing market.
- The large market share of this segment is primarily attributed to the large prevalence of infectious diseases such as COVID-19, malaria, dengue, gastrointestinal infections, tuberculosis, and HIV; rising adoption of laboratory instruments in hospitals and diagnostic labs; and technological advancements in terms of automation in microbiology testing.
Geographic analysis
North America
Largest shareIn 2025, North America is expected to account for the largest share of the global microbiology testing market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The large share of this market is primarily attributed to the large prevalence of infectious diseases, stringent GMP regulation for the manufacturing industry, high penetration of advanced microbiology testing products, and well-established distribution channel for microbiology testing products. North America to Dominate the Market
Competitive landscape
- Danaher Corporation (U.S.)
- Becton
- Dickinson and Company (U.S.)
- F. Hoffmann-La Roche Ltd · Switzerland
- Bruker Corporation (U.S.)
- Hologic, Inc. (U.S.)
- Bio-Rad Laboratories, Inc. (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- Merck KGaA · Germany
- Intertek Group plc (U.K.)
- Eurofins Scientific S.E · Luxembourg
- Agilent Technologies, Inc. (U.S.)
Frequently asked questions
The global microbiology testing market covers the market size & forecasts of the various microbiology testing products offered by key market players to various industries such as pharmaceutical, diagnostics, food and beverage, and cosmetics, among others. Microbiology testing products are used to detect and restrict harmful microorganisms. The microbiology testing market studied in this report involves the value analysis of various segments and sub-segments of microbiology testing product providers at the regional and country levels.
Cite this report
Meticulous Research. (2025). Microbiology Testing Market - Global Opportunity Analysis And Industry Forecast (2025-2032) (Report No. MRHC - 104778). Meticulous Market Research Pvt. Ltd. https://www.meticulousresearch.com/product/microbiology-testing-market-5462